Obesity is defined as excessive fat accumulation caused by the imbalance of energy intake versus expenditure. Low-grade chronic inflammation is a hallmark of obesity, and it is closely linked to insulin resistance. Obesity-induced inflammation and its associated metabolic dysfunctions underlay pathological processes of many chronic diseases such as insulin resistance, diabetes, sarcopenia and cardiovascular disease. Ghrelin is the only known circulating orexigenic hormone; it stimulates growth hormone release, and increases adiposity and insulin resistance. Ghrelin's functions are mediated through its receptor, growth hormone secretagogue receptor (GHS-R). The brain plays a critical role in energy homeostasis and energy metabolism. GHS-R is primarily expressed in the brain; the brain is a key ghrelin targeting site. The current review discusses the insights we have gained from global GHS-R knockout mice and neural conditional GHS-R knockout mice, specifically involving the roles of GHS-R in food intake, feeding adaptation, thermogenesis, meta-inflammation, and physical activity.
Obesity is the consequence of the imbalance of energy intake versus expenditure. It is characterized by increasing fat accumulation in adipose tissues and non-adipose tissues such as liver and muscle. Obesity-induced metabolic impairment promotes low grade chronic inflammation in a wide range of peripheral tissues; this metabolicallytriggered inflammation is termed "meta-inflammation" 1, 2 . Metainflammation elicits further metabolic dysfunctions in insulin targeting tissues such as adipose tissues, liver and muscle. The vicious cycle between metabolic dysfunction and inflammation underlies pathological processes of many chronic diseases such as obesity, insulin resistance, diabetes and cardiovascular disease. Thus, obesity is a major risk factor for the development of insulin resistance, type 2 diabetes, cardiovascular disease, and muscle dysfunction 3, 4 . Hypothalamus is a key site for the regulation of energy homeostasis; it senses the energy status of the body by receiving hormonal signals from ghrelin, leptin and insulin, and modulates feeding behavior and energy expenditure 5, 6 . Neuronal dysregulation in the hypothalamus is a major pathological hallmark of obesity 7 . Reducing energy intake (such as reducing food take) and/or increasing energy expenditure (such as increasing physical activity and/or non-shivering thermogenesis) offer promising strategies for combating obesity.
Ghrelin is the only known circulating orexigenic hormone associated with growth hormone release, meal initiation, adiposity and insulin resistance 8 . Ghrelin is ubiquitously expressed, and the highest expression is detected in the stomach and gut 8 . Ghrelin increases body weight by increasing food intake through its receptor, growth hormone secretagogue receptor (GHS-R) 8 . GHS-R is primarily expressed in the brain, with the highest expression in the hypothalamus and relatively lower expression in other brain regions 8, 9 . Low levels of GHS-R expression are also detectable in peripheral tissues such as macrophages, muscle, and white and brown adipose tissues 10, 11 . Studies have shown that circulating ghrelin and GHS-R expression in tissues are altered under the conditions of high-fat dietfeeding, obesity and aging 9, 12 . These findings suggest that ghrelin-GHS-R signaling may be involved in the regulation of energy homeostasis. The brain has a major role in energy regulation, and it is a key targeting site of ghrelin signaling. While we and others have published a number of papers using GHS-R global knockout mice 13, 14 , the neuron-specific roles of GHS-R and the specific site of actions of GHS-R in the brain remain unaddressed. To tackle this important question, we have generated two new GHS-R conditional knockout mice to investigate the functions of GHS-R in neurons. In this review, we will discuss the insights we have gained from both GHS-R global and neural conditional GHS-R knockout mice.
The Effect of GHS-R on Food Intake
GHS-R is expressed in orexigenic agouti-related peptide (AgRP)/neuropeptide Y (NPY), but not in anorexic proopiomelanocortin (POMC) neurons in the hypothalamus 6 . Ghrelin promotes food intake and increases body weight by simultaneously stimulating AgRP/NPY neurons and suppressing POMC neurons 15, 16 . Even though pharmacological administration of ghrelin has robust orexigenic effect, we found that total food intake of Ghsrnull mice does not change regardless of age or diet 13, 17, 18 . Interestingly, however, we found that Ghsr-null mice ate larger meals and had decreased feeding frequency 19 . We recently reported that ablation of GHS-R abolishes the ghrelin-induced excitatory effect on AgRP/NPY neurons, indicating that GHS-R is essential for ghrelin-induced excitation of AgRP/NPY neurons 20 . The inhibitory effect of ghrelin on POMC neurons is thought to be an indirect effect, mediated by increasing GABAergic synaptic input from NPY/AgRP neurons 15, 16, 21 . Interestingly, our study showed that blocking GABAergic receptors with gabazine increased the basal firing activity of POMC neurons in both wild-type and GHS-R null mice, and ghrelin excites POMC neurons of GHS-R null mice in the presence of gabazine 20 .
Our new findings suggest that ghrelin may regulate POMC neurons through an unidentified mechanism, independent from GABAergic synaptic input into POMC neurons. Collectively, these findings support that GHS-R is essential for ghrelin-induced excitation of AgRP/NPY neurons, but not for ghrelin-induced suppression of POMC; GHS-R is not required for long-term total energy intake of the mice.
The Role of GHS-R on Feeding Adaptation
GHS-R is also expressed in dopaminergic (DAergic) neurons in the ventral tegmental area (VTA), albeit to a much lesser extent than that observed in the arcuate nucleus 22 . Notably, ghrelin administration directly into the VTA augments palatable food intake and food-seeking behaviors 23 , indicating that this population of receptors is central in control of critical aspects of feeding. It is hypothesized that ghrelin controls these functions through modulation of DAergic neuronal activity. Indeed, ghrelin application depolarizes VTA DAergic neurons 24 , an effect dependent on excitatory synaptic input to these cells that lends credibility to this notion. In a recent series of studies, we discovered that blockade of GHS-R signaling with the antagonist D-Lys-GHRP-6 abolished tonic DAergic firing in the VTA of male rats 25 . This finding indicates that GHS-R activity, through an unknown mechanism, controls dopamine firing independent of ghrelin. We also find that D-Lys-GHRP-6 treatment was ineffective to alter tonic DAergic firing in rats that received weight loss surgery, and these rats displayed low circulating ghrelin concentrations in the blood and reduced hedonic intake of palatable food 25 .
Collectively, these studies suggest that the ghrelin ligand regulates GHS-R activity through alternative mechanisms to control palatable food intake and the feeding motivation.
GHS-R is a constitutively active G protein-coupled receptor (GPCR), which is able to initiate signaling activation in the absence of ligand ghrelin 26, 27 . GHS-R has the ability to form heterodimers with other GPCRs, such as dopamine receptors, melanocortin 3 receptors, and serotonin 2C receptors 26, 28, 29 , and these dimerization's alter the neuronal circuits of feeding behavior 26 . It has been reported that the formation of heterodimers between GHS-R and dopamine receptor 2 modifies dopamine signaling, resulting in Gβγ subunit-dependent but calcium mobilization-independent GHS-R basal activation 28 . It was also fund that dopamine receptor 2 agonist suppresses appetite in both wild-type and ghrelin-null mice, but not in GHS-R null mice 28 . The data suggest that the dopamineinduced appetite suppression is GHS-R dependent, but not ghrelin-dependent. The functional significance and molecular mechanism of GHS-R constitutive activity needs to be further investigated.
The Role of GHS-R in Thermogenesis
Emerging evidence suggests that non-shivering thermogenesis in brown adipose tissue plays a crucial role in energy homeostasis in both rodents and humans 30, 31 . Thermogenic capacity in the body positively correlates with energy expenditure, but negatively correlates with body fat mass. Obesity reduces thermogenesis in brown adipose tissue (BAT) through down-regulation of mitochondrial biogenesis and dysregulation of mitochondrial dynamics, as shown by us and others 12, 31, 32 . Under a cold environment, the sympathetic nervous system (SNS) releases norepinephrine (NE), which in turn activates β 3-adrenergic receptor (β 3-AR) in brown adipocytes. The β 3-AR signaling activates intracellular signaling cascade, such as the protein kinase A (PKA)-hormone-sensitive lipase (HSL) axis, to increase thermogenesis by activation of mitochondrial uncoupling protein 1 (UCP1) in brown adipocytes. We have reported that aging GHS-R null mice are lean and insulin-sensitive, showing increased thermogenic activation in BAT 12 . In addition to BAT, studies also indicate that "beige" adipocytes in subcutaneous adipose tissues are also involved in thermogenesis 31, 33 . While BAT and subcutaneous adipose tissues are the sites for thermogenesis, the sympathetic nervous system (SNS) involving many brain regions is the driver of thermogenic activation 34 . To distinguish the roles of GHS-R in neurons from peripheral tissues, we generated a conditional knockout mouse line using neuron-specific driver of Synapsin-cre. Remarkably, we found that neuronal deletion of GHS-R completely prevents diet-induced obesity 9 . High-fat diet (HFD)-fed neuronal-specific GHS-R deficient young mice have increased expression of thermogenic regulators (UCP-1, UCP-3, PGC-1α and β3-AR) in both BAT and subcutaneous fat tissues under cold exposure 9 . Furthermore, our data indicate that neuronal GHS-R deletion regulates genes mediating central thermogenic activation in ventromedial hypothalamus (VMH), paraventricular nucleus (PVN) and lateral hypothalamus (LH), implying elevated sympathetic outflow to brown adipose tissue and "beige" subcutaneous adipose tissues 9 . To further identify the specific site that governs GHS-R mediated SNSthermogenic regulation, we further generated a conditional knockout mouse line specifically targeting AgRP neurons 35 . Our data demonstrate that suppression of GHS-R in AgRP neurons mitigates diet-induced obesity by regulating thermogenic activity in brown and "beige" adipocytes 35 . However, the thermogenic phenotype and protective effect on diet-induced obesity of AgRP-specific GHS-R knockout mice was less pronounced when compared to that of GHS-R total neuronal knockout mice 9, 35 . This result indicates that neurons other than AgRP neurons likely contribute to centrally-mediated thermogenesis, and further studies are needed to identify the additional sites governing GHS-R mediated sympathetic activation.
The Role of GHS-R on Meta-Inflammation in Adipose Tissues
Metabolically-triggered "meta-inflammation" is a hallmark pathology of obesity and insulin resistance, and macrophages are a primary source of inflammatory effectors that contribute to meta-inflammation 1 . Macrophages are present as monocytes in the circulation, or as infiltrated or resident macrophages in the tissues [36] [37] [38] [39] . Macrophages utilize both endocrine and paracrine mechanisms to elicit systemic and tissue-specific effects [36] [37] [38] [39] . In response to environmental signals of various stimuli, macrophages undergo dynamic changes and reprogram to either pro-inflammatory or anti-inflammatory states 2, 39 .
We showed that GHS-R expression in mature peritoneal macrophages is increased during aging 39 . We reported that GHS-R deletion reduces pro-inflammatory cytokine expression in white and brown adipose tissues, which suggests the GHS-R activation promotes pro-inflammatory polarization in macrophages 39 . Some studies suggest that ghrelin's effect in macrophages may be mediated by scavenger receptor CD36 and peroxisome proliferator activated receptor γ (PPARγ) 40, 41 . Lucchi et.al showed that ghrelin activates PPARγ in hippocampus; intriguingly, ghrelin-induced PPARγ immunoreactivity in hippocampus remains intact in mice treated with GHS-R antagonist, and PPARγ antagonist counteracts the effect of GHS-R antagonist 42 . These findings suggest ghrelin and GHS-R may activate different signaling pathways in macrophages, and ghrelin's effect in macrophages could be independent of GHS-R. We have also observed that GHS-R deletion attenuates dietary insult-induced inflammation and lipid accumulation in adipose tissue and liver 18 . Global Ghsr-null mice are protected against high fructose corn syrup (HFCS)-induced adipose inflammation and insulin resistance; the adipose tissue macrophages of Ghsr-null mice showed decreased M1, but increased M2 18 . These results support that GHS-R contributes to meta-inflammation in adipose tissues by regulating macrophage polarization and macrophage-associated adipose tissue inflammation and insulin resistance.
The Role of GHS-R on Physical Activity
Physical inactivity and sedentary lifestyle are crucial determinants for being overweight or obese in a Western population, and the incidences of obesity are significantly higher in aging population 43 . Exercise is thought to be an effective treatment of obesity in humans and rodents by increasing energy expenditure. Reduced physical activity is common in the elderly; this is often associated with the abnormality of neurotransmitter transduction as well as reduction of muscle mass/function 44 . Interestingly, several recent studies have demonstrated that ghrelin administration rescues skeletal muscle atrophy in rodents 45 .
Under normal physiological conditions, dopamine active transporter (DAT) regulates neurotransmitter dopamine tone by increasing re-uptake of dopamine from synaptic cleft into presynaptic ending of neurons to regulate physical activity 46 . In obesity-prone rats, total DAT expression and function are significantly reduced compared to that of obesity-resistant rats; this suggests that the DAT function is critical in preventing diet-induced obesity 47 . Moreover, the loss of dopaminergic neurons in the substantia nigra (SN) is one of the underlying mechanisms for the development of Parkinson's disease 48 . Physical activity consists of spontaneous and voluntary activities; spontaneous activity is the term used for obligatory activities including eating and grooming, while voluntary activity is referred to as self-motivated movements such as exercise. Neuronal GHS-R deletion simultaneously promotes both spontaneous and voluntary activity, and has differential effects in different dopaminergic neurons in midbrain 9 . GHS-R deletion decreases dopaminergic activity in the ventral tegmental area (VTA) by downregulating DAT, but increases dopaminergic activity by up-regulating the expression of both dopamine synthesis enzyme (TH) and DAT in SN of HFD-fed neuronal-specific GHS-R knockout mice 9 . The data suggest that dopamine turnover and activity might be elevated in SN, which is in line with increased physical activity observed in HFDfed neuronal-specific GHS-R knockout mice. We did not observe the enhanced physical activity in our AgRPneuron-specific GHS-R knockout mice, suggesting that GHS-R in AgRP neurons does not contribute to the physical activity phenotype seen in total neuronal Ghsr knockout mice 35 . Our data collectively suggest that ghrelin signaling regulates centrally-mediated physical activity through finetuning of dopaminergic activity in midbrain.
As summarized in Figure 1 , our studies collectively indicate that neuronal GHS-R is required for the regulation of energy expenditure under obese condition or aging. GHS-R is critical for centrally-mediated thermogenesis and physical activity, specifically, hypothalamic neurons are important sites mediating the effects of GHS-R on thermogenesis, whereas dopaminergic neurons in midbrain control the effects of GHS-R on feeding adaptation and physical activity. Our data also reveal that GHS-R has important role in macrophage polarization; macrophages are key mediator of meta-inflammation in wide range of peripheral tissues, closely linked to insulin resistance. Thus, GHS-R has an important role in pathogenesis of obesity; it is a critical regulator of energy homeostasis, meta-inflammation and metabolic dysfunctions. GHS-R suppression presents a promising strategy for obesity control through multiple cellular and molecular Figure 1 . Functions of ghrelin and GHS-R signaling in obesity. Ghrelin and GHS-R signaling under aging or diet-induced obesity: 1) Systemic deletion of GHS-R activates basal firing activity of POMC neurons while GABAergic receptors are blocked, suggesting that ghrelin may activate POMC via an alternative mechanism other than GHS-R. 2) Deletion of GHS-R prevents age-associated thermogenic impairment in BAT by regulating thermogenic and insulin signaling cascades. The neuron-specific deletion of GHS-R increases thermogenesis by augmenting SNS output. GHS-R ablation improves mitochondrial function of brown adipocytes by up-regulating mitochondrial biogenesis and enhancing dynamics.
3) The neuron-specific deletion of GHS-R increases energy expenditure by enhancing physical activity and/or modifying feeding behaviors through modulation of dopaminergic neurons in midbrain. 4) Deletion of GHS-R attenuates inflammation (decreasing M1 macrophages) and reduces adiposity in both white and brown adipose tissues under diet-induced obesity and aging. The number annotated under the image is correlated with the summary points in the legend.
